Christopher Pierce
No más puestos en curso
Historial de carrera de Christopher Pierce
Antiguos cargos conocidos de Christopher Pierce.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 01/07/2020 | 30/09/2021 |
| Scout Advisers LLC | Corporate Officer/Principal | 01/08/2019 | 01/07/2020 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/04/2017 | 01/05/2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01/07/2016 | 01/03/2017 |
Formación de Christopher Pierce.
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
| Scout Advisers LLC |
- Bolsa de valores
- Insiders
- Christopher Pierce
- Experiencia
